IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -100.0% | 66 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $10,346,000 | +58.0% | 127,457 | +5.2% | 1.20% | +30.6% |
| Q4 2018 | $6,548,000 | +42.5% | 121,117 | +35.9% | 0.92% | +63.7% |
| Q3 2018 | $4,596,000 | +23.8% | 89,100 | 0.0% | 0.56% | +12.2% |
| Q2 2018 | $3,713,000 | -70.4% | 89,100 | -68.6% | 0.50% | -71.7% |
| Q1 2018 | $12,523,000 | -3.9% | 284,100 | +9.6% | 1.76% | -37.6% |
| Q4 2017 | $13,033,000 | -0.7% | 259,100 | +0.0% | 2.82% | +7.0% |
| Q3 2017 | $13,131,000 | -0.3% | 259,000 | 0.0% | 2.63% | -3.6% |
| Q2 2017 | $13,175,000 | +26.5% | 259,000 | 0.0% | 2.73% | +21.5% |
| Q1 2017 | $10,412,000 | -16.0% | 259,000 | 0.0% | 2.25% | -18.3% |
| Q4 2016 | $12,388,000 | +30.5% | 259,000 | 0.0% | 2.75% | +31.6% |
| Q3 2016 | $9,490,000 | +67.4% | 259,000 | +85.0% | 2.09% | +75.9% |
| Q1 2016 | $5,670,000 | +205.2% | 140,000 | +600.0% | 1.19% | +218.5% |
| Q4 2015 | $1,858,000 | – | 20,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |